Market open
GT Biopharma Inc/$GTBP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GT Biopharma Inc
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Ticker
$GTBP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1
ISIN
US36254L3087
Website
GT Biopharma Inc Metrics
BasicAdvanced
$5.9M
-
-$6.94
0.59
-
Price and volume
Market cap
$5.9M
Beta
0.59
52-week high
$2.70
52-week low
$2.09
Average daily volume
19K
Financial strength
Current ratio
0.717
Quick ratio
0.669
Management effectiveness
Return on assets (TTM)
-97.90%
Return on equity (TTM)
-453.39%
Valuation
Price to book
-3.13
Price to tangible book (TTM)
-3.13
Price to free cash flow (TTM)
-0.344
Growth
Earnings per share change (TTM)
23.06%
3-year earnings per share growth (CAGR)
-51.77%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GT Biopharma Inc stock?
GT Biopharma Inc (GTBP) has a market cap of $5.9M as of May 09, 2025.
What is the P/E ratio for GT Biopharma Inc stock?
The price to earnings (P/E) ratio for GT Biopharma Inc (GTBP) stock is 0 as of May 09, 2025.
Does GT Biopharma Inc stock pay dividends?
No, GT Biopharma Inc (GTBP) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next GT Biopharma Inc dividend payment date?
GT Biopharma Inc (GTBP) stock does not pay dividends to its shareholders.
What is the beta indicator for GT Biopharma Inc?
GT Biopharma Inc (GTBP) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.